N-(3-hydroxymethyl-β-carboline-1-yl-ethyl- 2-yl)-l-Phe: development toward a nanoscaled antitumor drug capable of treating complicated thrombosis and inflammation.
about
N-(3-hydroxymethyl-β-carboline-1-yl-ethyl- 2-yl)-l-Phe: development toward a nanoscaled antitumor drug capable of treating complicated thrombosis and inflammation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 January 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
N-(3-hydroxymethyl-β-carboline ...... d thrombosis and inflammation.
@en
type
label
N-(3-hydroxymethyl-β-carboline ...... d thrombosis and inflammation.
@en
prefLabel
N-(3-hydroxymethyl-β-carboline ...... d thrombosis and inflammation.
@en
P2093
P2860
P356
P1476
N-(3-hydroxymethyl-β-carboline ...... d thrombosis and inflammation.
@en
P2093
Haimei Zhu
Jianhui Wu
Shiqi Peng
Shurui Zhao
Xiaoyi Zhang
Yaonan Wang
P2860
P304
P356
10.2147/DDDT.S123919
P407
P577
2017-01-17T00:00:00Z